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Abstract
Background: Dry eye is a common disease worldwide, and animal models are critical for the study of it. At present, there is
no research about the stability of the extant animal models, which may have negative implications for previous dry eye
studies. In this study, we observed the stability of a rabbit dry eye model induced by the topical benzalkonium chloride
(BAC) and determined the valid time of this model.
Methods and Findings: Eighty white rabbits were randomly divided into four groups. One eye from each rabbit was
randomly chosen to receive topical 0.1% BAC twice daily for 2 weeks (Group BAC-W2), 3 weeks (Group BAC-W3), 4 weeks
(Group BAC-W4), or 5 weeks (Group BAC-W5). Fluorescein staining, Schirmer’s tests, and conjunctival impression cytology
were performed before BAC treatment (normal) and on days 0, 7, 14 and 21 after BAC removal. The eyeballs were collected
at these time points for immunofluorescence staining, hematoxylin and eosin (HE) staining, and electron microscopy. After
removing BAC, the signs of dry eye in Group BAC-W2 lasted one week. Compared with normal, there were still significant
differences in the results of Schirmer’s tests and fluorescein staining in Groups BAC-W3 and BAC-W4 on day 7 (P,0.05) and
in Group BAC-W5 on day 14 (P,0.05). Decreases in goblet cell density remained stable in the three experimental groups at
all time points (P,0.001). Decreased levels of mucin-5 subtype AC (MUC5AC), along with histopathological and
ultrastructural disorders of the cornea and conjunctiva could be observed in Group BAC-W4 and particularly in Group BAC-
W5 until day 21.
Conclusions: A stable rabbit dry eye model was induced by topical 0.1% BAC for 5 weeks, and after BAC removal, the signs
of dry eye were sustained for 2 weeks (for the mixed type of dry eye) or for at least 3 weeks (for mucin-deficient dry eye).
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Introduction
Dry eye is a common disease worldwide [1]. Clinical epidemi-
ological surveys have demonstrated that in 1995, 17% of the
outpatients in Japan reported symptoms of dry eye [2], and in 1997,
14.6%ofthe U.S.populationwho rangedinagefrom 65to84years
showed symptoms of dry eye [3]. In 2003, approximately 33.7% of
theelderlypopulationofTaiwan(thoseovertheageof65years)also
reported symptoms of dry eye [4]. The high prevalence of dry eye
has already evoked the close attention of scholars from all over the
world, so there has been a great advancement in dry eye research
overthe lastdecade.Dryeyehasbeen redefined ina reportfromthe
Dry EyeWorkShop(DEWS), which summarized the results of these
studies. Increased osmolarity of the patient’s tears and inflammation
of the ocular surface were added to the new definition, and the
potential damage to the ocular surface was clearly indicated [5].
However, there is still much to be learned from the study of the dry
eye disease because dry eye is a multifactorial and complex disease.
Standard experimental animals are primary agents that directly
impact the accuracy of experimental results. The investigation of
dry eye is imperative for determining both its causes and
appropriate treatments for it, and several animal models have
been created. For example, Susi built a rabbit model of dry eye
using a topical administration of 1% atropine and observed the
model for 6 days [6]. Barabino constructed a murine dry eye
model that used a controlled environment of temperature,
humidity, and wind velocity to induce the condition; this model
was observed for 28 days [7]. In his subsequent experiments,
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days [8,9]. Dursun built a dry eye model in Sprague-Dawley (SD)
rats by applying transdermal scopolamine and placing the model
animals in a desiccating environment for 4 days [10]; in other
experiments, these authors used a number of different treatment
durations (4 hours, 1 day, 2 days, 3 days, 5 days, 10 days, 12 days
and so on) to validate their model according to various detection
indices of dry eye [11–14]. Wei Chen et al. established a murine
dry eye model that used an intelligently controlled environmental
system for 42 days to establish the condition [15]. In subsequent
experiments, they chose to treat the mice for 21 days [16]. The
current authors have previously built a rabbit model of dry eye
using a topical application of 0.1% benzalkonium chloride (BAC)
for 2 weeks [17]. In addition to the aforementioned studies, many
other methods of building animal models of dry eye have been
reported [18–23].
When we used our rabbit dry eye model for the experiment that
is described in this article, we found that some indices of the rabbit
models showed that the animals tend to recover within two weeks
of successfully establishing the dry eye model. This phenomenon
suggested that this model of dry eye was not stable. After reviewing
the literature, we found that all of the standards for evaluating dry
eye models have depended solely on signs of dry eye that are
detected when the animal models were correctly created, and we
discovered that no one had conducted follow-up research on these
models [6,7,10,15].
As a result of this discovery, we designed this experiment to
observe the stability of a rabbit model of dry eye following the
cessation of regular BAC administration; to be more specific, we
decided to observe the duration over which dry eye signs were
maintained in rabbits after successfully building the model, and in
doing so, we determined the temporal validity of this model. The
results of this experiment would both validate this model of dry eye
and determine whether it is a reliable tool for dry eye research.
Materials and Methods
Animals and Experimental Procedure
All of the procedures in this experiment were performed in
accordance with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research and were approved by the
animal ethics committee of Zhongshan Ophthalmic Center, Sun
Yat-sen University (approval ID: 2008-027). Eighty female New
Zealand white rabbits (2–2.5 kg, purchased from the Guangdong
Medical Laboratory Animal Center, Guangdong, China) were
used for this study. The environmental standards throughout this
study were the same as in our previous study [17]; rabbits were
housed at a room temperature of 23uC62uC with a relative
humidity 60%610%, and alternating 12-h light-dark cycles (8
A.M. to 8 P.M.). The eighty rabbits were randomly divided into
four groups (BAC-W2, BAC-W3, BAC-W4 and BAC-W5), and
one eye from each rabbit was randomly chosen as the
experimental eye. This eye was treated with a twice-daily (8
A.M. and 4 P.M.) topical administration of 0.1% BAC (Sigma, St.
Louis, MO, USA). Group BAC-W2 was medicated for 2 weeks,
Group BAC-W3 was medicated for 3 weeks, Group BAC-W4 was
medicated for 4 weeks, and Group BAC-W5 was medicated for 5
weeks. Fluorescein staining, Schirmer’s tests, and the conjunctival
impression cytology were performed sequentially following the
methods described below. These tests were performed prior to
treatment (normal), immediately after the cessation of the BAC
administrations (day 0) and 1 week (day 7), 2 weeks (day 14), and 3
weeks (day 21) after stopping the BAC treatment. Before
beginning the BAC treatment, one rabbit from each group was
randomly chosen to be sacrificed, and the ocular global tissues
from each of these animals were carefully dissected and prepared
for immunofluorescence staining, hematoxylin and eosin (HE)
staining, and scanning and transmission electron microscopy
according to the methods that are described below. In addition,
two rabbits from each group were randomly chosen on days 0, 7,
14 and 21 after the cessation of BAC treatment and were
sacrificed, after which the ocular global tissues from these animals
were dissected and prepared for staining and microscopy.
Measurement of Aqueous Tear Secretion
Aqueous tear secretion was measured with a modified Schirmer
I test using strips of Whatman 41 filter paper (Tianjin Jingming
New Technology Development Co. Ltd., Tianjin, China). Tests
were conducted at the same time points on prearranged days in
the standard environment by the same person. Intramuscular
injections of a mixture of 25 mg ketamine and 25 mg chlorprom-
azine were administered to keep the rabbits immobile. After a
topical administration of Alcaine (Alcon, Fort Worth, TX, USA),
we pulled the lower eyelid down slightly and placed the paper strip
for the Schirmer’s test on the palpebral conjunctival vesica, which
is near the junction of the middle and outer third of the lower lid.
After 5 min, the wetted length (in millimeters) of the paper strip
was read. Each eye was tested 3 times, and the average length of
wetted paper was taken as the final length.
Fluorescein (FL) Staining
Two microliters of a 1% sodium fluorescein solution (Zhong-
shan Ophthalmic Center, Guangzhou, China) were introduced
into the conjunctival sac; 2 minutes after instillation, any
superfluous sodium fluorescein sodium was washed out with a
normal saline solution. The staining was then examined under a
slit lamp microscope with a cobalt blue filter (Topcon, Tokyo,
Japan) and recorded. The cornea was divided into four quadrants,
each of which was scored as follows: no staining was given a score
of 0; slight, punctate staining of fewer than 5 spots was given a
score of 1; punctate staining of more than 5 spots with no positive
plaque was given a score of 2; and the presence of a positive
fluorescein plaque was given a score of 3. The four scores were
then added to calculate the final grades, which had totals that were
between 0 and 12. This procedure was always performed by the
same person.
Conjunctival Impression Cytology (CIC)
Following an intramuscular injection of a mixture of 25 mg
ketamine and 25 mg chlorpromazine, 2 3.5 mm63.5 mm circular
disks of nitrocellulose filter paper (Pall, New York, NY, USA) were
placed separately on the nasal and temporal bulbar areas of the
conjunctiva with the dull sides of the filter paper down and held in
place for 10 seconds under constant pressure. The filter paper was
then gently lifted and treated with 95% alcohol. Periodic acid-
Schiff (PAS) reagents were used to stain the specimens. Once the
papers had been stained, the number of goblet cells in each
impression was counted under a microscope (Olympus, Tokyo,
Japan) using a 406 objective. Three different sections of each
specimen were randomly selected for counting, the number of cells
in each section was counted, and an average number of cells was
calculated (cells/high-power [HP] visual field at 4006).
Immunodetection of MUC5AC
Immunodetection of MUC5AC was performed using immuno-
fluorescent staining of cryosections of the nasal and temporal
bulbar conjunctiva after the animals had been sacrificed. All
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specimens were washed three times in phosphate buffered saline
(PBS), they were blocked with 10% goat serum for 30 minutes at
room temperature, then incubated for 12 hours at 4uC with a
1:100 dilution of mouse anti-human MUC5AC antibody (Abcam,
355660, UK). After 3 more washes in PBS, the specimens were
incubated with ALEXA FLUOR secondary goat anti-mouse IgG
(Invitrogen, USA) for 30 minutes at room temperature, followed
by an additional 3 washes in PBS. Nuclei were counterstained with
0.5 g/mL Hoechst 33342 dye (Invitrogen, USA). Finally, the
specimens were observed under a fluorescent microscope (Zeiss,
Germany).
HE Staining of the Cornea
The corneas from sacrificed animals were fixed in 4% formalin
for 24 hours after the animals were killed. Briefly, after
dehydration, the specimens were embedded in paraffin, cross-
sectioned, and stained with hematoxylin and eosin (H&E). The
histologic morphology of each corneal specimen was examined
using light microscopy.
Scanning Electron Microscopy (SEM)
Prior to the onset of BAC treatment and on days 0, 7 and 21
after the cessation of BAC treatment, the corneas of animals that
had been sacrificed were fixed in a 2.5% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.4) for 24 h at 4uC. Specimens were then
postfixed with osmium tetroxide in 0.1 M phosphate buffer and
dehydrated in a graded series of ethanol solutions. Following
dehydration, the fixed specimens were critical-point dried, gold-
coated with platinum, and examined with a scanning electronic
microscope (JSM-6330F, JEOL, Japan).
Transmission Electron Microscopy (TEM)
Prior to the start of BAC treatment and on days 0, 7 and 21
following the cessation of BAC treatment, the corneas and
conjunctivas of animals that had been sacrificed were fixed via
incubation with a 2.5% glutaraldehyde solution in 0.1 M
phosphate buffer (pH 7.4) at 4uC for 24 h. They were then
postfixed with osmium tetroxide in 0.1 M phosphate buffer,
embedded in resin, and cut into 60-nm sections without disturbing
the epithelium. The specimens were examined and photographed
with a transmission electron microscope (H600, HITACHI, Japan)
Statistical Analysis
Statistical analyses were performed using the SPSS software
package, version 13.0. One-way ANOVAs (Bonferroni) were
applied to all of the comparisons of aqueous tear secretion and
conjunctival goblet cell density that were made among the groups.
A Wilcoxon signed-rank test (Bonferroni) was used for all of the
comparisons of FL scores among the groups that were studied. All
tests were two-tailed, and P-values that were less than 0.05 were
considered to be statistically significant.
Results
No baseline (normal) significant differences were found among
the four experimental groups.
Aqueous Tear Secretion Experiment
Compared with normal eyes, tear secretion declined rapidly in
the four groups after BAC treatment. There were statistically
significant differences on days 0 and 7 after treatment in Groups
BAC-W2, BAC-W3, and BAC-W4, but there were no significant
differences on days 14 and 21. However, when comparing tear
secretion with the baseline levels in Group BAC-W5, the
significant differences lasted until day 14 after the cessation of
treatment. No significant differences in the baseline tear secretions
of the four groups were recorded prior to the onset of BAC
treatment (Fig. 1).
Corneal Fluorescein Staining
At baseline, no differences in corneal epithelium fluorescein
staining were found among the four groups. Compared with
fluorescein staining in normal eyes, the scores for fluorescein
staining increased significantly after BAC treatment (p,0.001),
and these scores for epithelial damage remained significantly
higher than normal until day 14 after the cessation of BAC
treatment in all of the groups (p,0.05) (Fig. 2).
Conjunctival Impression Cytology and the Density of
Goblet Cells
There were no differences in the goblet cell densities of the four
groups at prior to the administration of BAC. The goblet cell
Figure 1. The results of Schirmer’s tests in all groups. Schirmer’s
test results show decreased aqueous tear secretion compared to pre-
treatment secretion levels on days 0, 7 and 21 after the cessation of BAC
treatment. *P,0.05, **P,0.01, ***P,0.001, respectively. Compared
with pre-treatment, the differences were statistically significant on days
0 and 7 in the BAC-W2, BAC-W3, and BAC-W4 groups as well as on days
0, 7 and 14 in Group BAC-W5. The values shown are average wetted
lengths 6 standard deviations.
doi:10.1371/journal.pone.0033688.g001
Figure 2. The scores for sodium fluorescein staining in all
groups. Compared with the pre-treatment group, there were
significant differences on days 0, 7 and 14 after the cessation of BAC
treatment in the BAC-W2, BAC-W3, BAC-W4, and BAC-W5 groups.
doi:10.1371/journal.pone.0033688.g002
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reduced on day 0 (P,0.001), but the number of goblet cells
continued to gradually increase with increases in the amount of
time that had elapsed since the cessation of BAC treatment. In
Group BAC-W2, this steady increase meant that by day 21, there
was no longer a statistically significant difference in the goblet cell
density in the eyes of Group BAC-W2 and that of the eyes of the
control group. Although the differences in Groups BAC-W3 and
BAC-W4 remained significant at all of the time points that were
examined, the number of goblet cells in each group tended to
recover. However, the trend in Group BAC-W5 was different
from that of the first three groups; goblet cell density increased
slowly over time until day 14, but on day 21, it decreased to the
same level as it had been on day 0 (Fig. 3, Fig. 4).
Immunofluorescence for MUC5AC
The changing tendencies of immunofluorescence for MUC5AC
in the four groups were consistent with the results of PAS staining
(Fig. 5).
Light Microscopy
HE staining of the cornea showed that before BAC treatment,
the corneas in all four groups had three to five epithelial layers. In
all four groups, the corneal epithelia were thinner on days 0 and 7
than they were prior to the start of treatment, and the cells in them
were arranged in a disordered manner. This was especially true for
the Group BAC-W5 animals; in these animals, the corneal
epithelia became significantly thinner, and in some areas, the
epithelial surface cells showed abnormal phenomena (Fig. 6).
Scanning Electron Microscopy (SEM)
After the conclusion of BAC treatment, the number of microvilli
on the corneal surface decreased significantly, the microvilli
became shorter and irregularly arranged, and the micropores on
the cell membrane decreased or even completely disappeared.
This phenomenon was observable on days 0 and 7 in groups BAC-
W2, BAC-W3 and BAC-W4 and on days 0, 7, and 21 in Group
BAC-W5. As the amount of time that had elapsed after the
cessation of BAC applications increased, the microvilli and
micropores of the epithelial cells in Groups BAC-W2 and BAC-
W3 gradually returned to normal levels by day 21. The number
and morphology of microvilli in Group BAC-W4 recovered to
normal on day 21, but the number of micropores was still slightly
less than that it was prior to treatment. The numbers of both
microvilli and micropores in Group BAC-W5 were still lower on
day 21 compared with the numbers of microvilli and micropores
in samples from the pre-treatment animals (Fig. 7).
Transmission Electron Microscopy
Corneal Epithelial Ultrastructure. On day 0, necrosis of
the corneal epithelium could be observed in each group, especially
Group BAC-W5, and the corneal epithelial surface cells were
detached in some areas, which resulted in significant levels of
Figure 3. The number of goblet cells in all groups. Compared
with the goblet cell densities in normal eyes, there were significant
differences on days 0, 7 and 14 in Group BAC-W2, and on days 0, 7, 14
and 21 in Groups BAC-W3, BAC-W4 and BAC-W5. In the last of these
(Group BAC-W5), there were no significant differences in goblet cell
density between days 0 and 21. The values shown are averages6
standard deviations.
doi:10.1371/journal.pone.0033688.g003
Figure 4. Representative examples of CIC in each group. Each group showed evidence of having an abundance of goblet cells, and the goblet
cells were oval in shape and full when normal. On day 0, there were only a few goblet cells in all of the groups, and these goblet cells were irregularly
shaped. This difference from baseline could be observed on days 0, 7 and 14 in Group BAC-W2 and on days 0, 7, 14, and 21 in groups BAC-W3, BAC-
W4 and BAC-W5.
doi:10.1371/journal.pone.0033688.g004
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and organelle damage, such as swelling of the mitochondria, Golgi
apparati and the rough endoplasmic reticulum (RER).
The damage that had been caused by treatment with BAC
gradually abated in Groups BAC-W2, BAC-W3 and BAC-W4
until day 21; the cellular ultrastructure nearly returned to normal
in Groups BAC-W2 and BAC-W3 whereas the situation remained
severe in Group BAC-W5 (Fig. 8, Fig. 9).
Conjunctival Ultrastructure. By the end of the period in
which model animals were treated with BAC, the conjunctival
epithelia had become thinner. The goblet cells were in a necrotic
state, and we could see that the levels of secretory granules in the
goblet cells had either diminished substantially or that the granules
had disappeared altogether. Some epithelial cells necrotized, which
indicated chromatin margination or cell membrane rupture.
On day 7, the conjunctival epithelia from Group BAC-W2
samples showed evidence of recovery, and on day 21, the
conjunctival epithelia were rich in goblet cells and showed the full
and normal shapes of secretory granules. Samples from Group
BAC-W3 animals exhibited similar trends to those from Group
BAC-W2.
In Group BAC-W4, some goblet cells that contained secretory
granules could be observed in the conjunctival epithelium on day
7, and on day 21, goblet cells that had abundant numbers of
secretory granules in the secretion phase could be found in some
areas. However, the goblet cells in other areas remained damaged;
in these areas, fewer secretory granules were present, and the areas
were not stained as darkly as comparable areas were prior to
treatment (presumably because the quality of mucin that was
secreted by the goblet cells had degraded).
In Group BAC-W5, a specific number of secretory granules
contained in the goblet cells could be observed on day 7, and the
conjunctival epithelium appeared to have a more regular form that
indicated that it was in an improved state. It is worth noting,
however, that the damage that had been caused by regular
applications of BAC remained severe in Group BAC-W5 on day
21; most of the goblet cells had no obvious secretory granules, and
even dead goblet cells could be observed (Fig. 10).
Figure 5. Representative images of immunofluorescence staining in all groups. Prior to treatment, the staining pattern for mucin MUC5AC,
which is primarily secreted by the goblet cells, was abundant, and the cells that secrete it were plump and oval in shape. On day 0, the presence of
MUC5AC was rare in all of the groups, and the shapes of cells that contained MUC5AC were irregular. This change could also be observed on days 0,
7, 14 in Group BAC-W2; and on days 0, 7, 14 and 21 in Groups BAC-W3, BAC-W4 and BAC-W5.
doi:10.1371/journal.pone.0033688.g005
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Inflammation and increased tear osmolarity have been
proposed as specific new additions to the definition of the dry
eye disease that was reported by the Dry Eye WorkShop (DEWS)
because the research regarding dry eye disease that has been
conducted in recent years shows that the core pathogenesis
mechanisms of dry eyes included heightened tear osmolarity and
an unstable tear film [5]. According to this mechanism of
pathogenesis, some symptoms of dry eye disease are due to
increased tear osmolarity that arises from various causes and that
can spur the ocular surface epithelial cells to produce and release
inflammatory mediators into the tear film. This in turn leads to an
inflammatory cascade that results in apoptosis of the ocular surface
epithelial cells, and reductions in goblet cell density reducing
[12,24]. Another hypothesis regarding the pathogenesis of dry eye
is one in which an unstable tear film that could be mainly caused
by a mucin deficiency on the ocular surface is the initial problem,
which implies that an increase tear osmolarity is not responsible
for the onset of dry eye symptoms. Clinical examples of the latter
include dry eye that results from the local administration of drugs
that contain BAC [25], and these provide an important clinical
basis of establishing this dry eye model. BAC is capable of
destroying the tight junctions that are located in the superficial
cells of the corneal epithelium [26]; this degradation of tight
junctions then damages the normal functioning of the corneal
epithelium [27]. Exposure to BAC can also lead directly to both
apoptosis of the conjunctival epithelium [28,29] and a decrease in
the number of goblet cells [30]. Thus, as previous research has
shown, the tear film becomes unstable and ceases to play its role in
protecting the ocular surface [31]. In addition to having this effect
on the cells themselves, BAC can stimulate the overexpression of
inflammatory mediators in the epithelium, such as ICAM-1, or
interleukins IL-6, IL-8, and IL-10 [32,33], which may also cause
apoptosis of both epithelial cells and goblet cells. The loss of these
Figure 6. Representative pictures of HE staining of the corneas
from each of the four groups. Normal corneas had three to five
epithelial layers. Damage to the epithelium could be observed on days
0 and 7 in the four groups.
doi:10.1371/journal.pone.0033688.g006
Figure 7. Representative images from scanning electron microscopy. Compared with normal eyes, there were fewer microvilli, and these
microvilli were shorter and less regularly arranged on days 0 and 7 in Groups BAC-W2, BAC-W3 and BAC-W4, and on days 0, 7, and 21 in Group BAC-
W5.
doi:10.1371/journal.pone.0033688.g007
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studies shows that in addition to the direct effect that BAC has on
goblet cell density, inflammation underlies decreases in mucin
expression. Reductions in the production of mucin speed up the
rate at which the tear film breaks up, thereby aggravating the
ocular surface damage and stimulating the inflammation cascade
of the ocular surface epithelial cells. Ultimately, this results in a
vicious cycle based on the core mechanisms of ocular surface
protection that eventually leads to the occurrence of dry eye
disease. A previous study demonstrated that the damage to the
ocular surface that resulted from BAC administration was both
dose- and time-dependent. The expression levels of apoptotic
markers increased, and corneal and conjunctival cells were
damaged immediately after in vitro exposure to a solution
containing 0.1% BAC [35]. BAC has a high affinity for binding
to ocular cells, and it can combine with the cellular plasma
membranes quickly and persistently, which then results in a series
of cellular alterations. At the same time, one drop of BAC can
remain on the ocular surface for as long as 48 hours [36].
Furthermore, the topical application of a 0.1% solution of BAC
did not cause severe damage to the ocular surface, such as
ulcerations, large epithelial defects, or neovascularization. We had
already constructed a rabbit dry eye model using a topical
application of a 0.1% solution of BAC that was administered for 2
weeks [17]. In follow-up experiments that were based on this
model, we found that the animal model that was established in this
manner lacked stability, which was probably because the
administration period was not long enough to cause permanent
changes, so the eye that experienced the symptoms of dry eye was
able to recover quickly. To obtain a stable animal model of dry eye
that could be used for subsequent research, we designed the
present experiment. We repeated the previous procedures that had
been used to generate various models. After the cessation of BAC
treatment, we observed both the self-recovery of the ocular
conditions of the experimental animals and some related indices.
Our results showed that the values of the indices that we measured
in each experimental group on day 0 after we stopped
administering the medication were consistent with the character-
istics of dry eye. This finding also agreed with the results of our
previous study [17] and those of studies that were conducted by
other researchers [10,15]. However, although some indicators of
dry eye persisted as the time over which we continued to observe
the model lengthened, some indices of the dry eye model that we
had established gradually recovered.
In the present study, the result of the Schirmer’s test showed
that in Group BAC-W5, the basic signs of reductions in tear
Figure 8. Representative images from transmission electron
microscopy. Compared with images from normal eyes, swelling of the
mitochondria, Golgi apparati and RER could be observed on day 0 in
Group BAC-W2, on days 0 and 7 in Groups BAC-W3 and BAC-W4, and on
days 0, 7, and 21 in Group BAC-W5.
doi:10.1371/journal.pone.0033688.g008 Figure 9. Representative images from transmission electron
microscopy that revealed the ultrastructure of the corneal
epithelium. Compared with normal eyes, vacuoles between the cells
could be observed on day 0 in Group BAC-W2 and on days 0, 7, and 21
in Groups BAC-W3, BAC-W4. These vacuoles were particularly promi-
nent among samples from Group BAC-W5.
doi:10.1371/journal.pone.0033688.g009
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BAC was stopped; in other groups, these indicators generally
returned to normal in the third week following the cessation of
treatment. This finding suggests that the early reduction in basic
tear secretion is probably due to direct damage of the accessory
lacrimal glands and the conjunctiva.
The results of corneal fluorescein staining showed that changes
in fluorescein staining, which reflects defects among the corneal
epithelial cells, could be sustained for 2 weeks after the cessation of
treatment in all of the rabbits, and that fluorescein staining
returned to normal levels on day 21. Combining this result with
the results of scanning and transmission electron microscopy, we
found that the BAC-induced damage to the corneal and
conjunctival ultrastructure could last for at least 21 days in Group
BAC-W5. This result revealed that although there were few
obvious defects in the corneal epithelial cells in Group BAC-W5
animals on day 21, damage to the corneal and conjunctival
ultrastructure may be secondary to inflammation that was
stimulated by BAC. This damage included facets such as the
shortening and lodging of microvilli on the corneal surface and the
reduction in micropores due to changes in cell metabolism.
MUC5AC is the most essential subtype of the family of ocular
surface mucins [37], and it is mainly secreted by the goblet cells. In
this study, the trends in the changes in MUC5AC immunofluo-
rescence in each group were consistent with the results of PAS
staining. MUC5AC production seemed to be recovering within
two weeks of the cessation of BAC treatments, but the expression
levels were still significantly reduced compared with normal levels.
This represents a recovery of the goblet cells due to the removal of
the direct effect of BAC on the ocular surface. However, the
numbers of goblet cells and the amounts of MUC5AC in Group
BAC-W5 specimens remained at significantly lower levels that
were as low on day 21 as they were on day 0. This behavior
resembled that which had been observed using transmission
electron microscopy, which showed that on day 21, the reduction
in the number of secretory granules in conjunctival goblet cells in
Group BAC-W5 was still significant compared with the number of
secretory granules in normal tissue. This could be because the
topical application of 0.1% BAC for 5 weeks resulted in a stable
inflammatory immune environment, in which the epithelium was
stimulated to express inflammatory mediators that then caused
goblet cell apoptosis and an inability to return to normal levels of
secretory granule production [34,35,38], despite the lack of a
direct effect of BAC on the goblet cells. The continued
insufficiency of MUC5AC production then resulted in an unstable
tear film [39], which in turn caused serial ocular damage and an
inflammatory environment. Thus, the eye entered a vicious cycle
that ultimately led to the development of dry eye. Therefore, we
think that the animal model in which dry eye is induced by 5
weeks of topical administration of 0.1% BAC is a stable model of
mucin deficiency that is associated with dry eye.
In this paper, we demonstrated that topical administration of
BAC for a period of 2–4 weeks could successfully produce an
animal model of dry eye that was both satisfactory and applicable.
This model could be used to study both the prevention and the
etiopathogenisis of dry eye, or it could be expanded by means of
some appropriate interventional measures in the modeling process.
A stable animal model of dry eye can be induced via a 5-week
Figure 10. Representative images from transmission electron microscopy showing the conjunctival epithelial ultrastructure.
Compared with normal eyes, fewer goblet cells and secretary granules were observed on day 0 in Groups BAC-W2 and BAC-W3, and on days 0, 7, and
21 in Group BAC-W4. This loss of goblet cells and secretary granules was particularly pronounced in Group BAC-W5 on all of the days that were
studied. Chromatin condensation and peripheral migration could be observed on days 0, 7, and 21 in Group BAC-W5.
doi:10.1371/journal.pone.0033688.g010
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that results from this model could last 2 weeks, and it could be used
for research regarding the water-deficient subtype of dry eye. It is
worth noting that including a control group that is based on the
model and for which the observation time is longer than the
current temporal window would make our results more credible.
Both the number of goblet cells and the secretory volume of
MUC5AC remained at low levels for 3 weeks after dry eye was
induced in the model animals; the diminished secretion state in the
goblet cells did not display any recovery after BAC was no longer
administered. All of the above phenomena demonstrate that the
topical administration of a 0.1% solution of BAC for 5 weeks
established a stable model of dry eye that included an extended
period over which the secretion of mucin proteins was diminished
relative to baseline levels. Due to the stability of this model and the
low levels of mucin secretion that it produces, this rabbit model
might be particularly appropriate for research regarding the
etiology and pathogenesis of dry eye and for research regarding
the therapeutic effects of medication and other treatments for dry
eye that is accompanied by mucin deficiency or epithelial damage.
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